| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Paravasthu Mukund | Chief Operating Officer | C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE | Steven Robbins, as attorney in fact for Paravasthu, Mukund | 05 May 2025 | 0002039078 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVCR | Ordinary Shares | Sale | $10,604 | -592 | -0.7% | $17.91 | 83,556 | 03 May 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| F2 | This transaction was executed in multiple trades at prices ranging from $17.8550 USD to $17.9498 USD; the price reported above reflects the weighted average sale price. |